These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33915303)

  • 41. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP
    Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Nonaka D; Asada K; Lee LJ; Tanaka K; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y
    J Gastroenterol; 2018 Nov; 53(11):1179-1185. PubMed ID: 29497816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable.
    Levin B; Smith RA; Feldman GE; Colditz GA; Fletcher RH; Nadel M; Rothenberger DA; Schroy PS; Vernon SW; Wender R;
    Cancer; 2002 Oct; 95(8):1618-28. PubMed ID: 12365008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
    Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
    Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.
    Castiella A; Múgica F; Zapata E; Zubiaurre L; Iribarren A; de Juan MD; Alzate L; Gil I; Urdapilleta G; Otazua P; Emparanza JI
    Tumour Biol; 2015 Sep; 36(9):6959-63. PubMed ID: 25854174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
    de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
    Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
    Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
    PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
    PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
    Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
    Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A hierarchical classifier based on human blood plasma fluorescence for non-invasive colorectal cancer screening.
    Soares F; Becker K; Anzanello MJ
    Artif Intell Med; 2017 Oct; 82():1-10. PubMed ID: 28939302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer
    Nannini G; Meoni G; Tenori L; Ringressi MN; Taddei A; Niccolai E; Baldi S; Russo E; Luchinat C; Amedei A
    World J Gastroenterol; 2021 Oct; 27(38):6430-6441. PubMed ID: 34720532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
    Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
    Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
    Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
    Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
    Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
    J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of colorectal neoplasia by using serum bile acid profile.
    Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Takagi T; Konishi H; Kuriu Y; Nakanishi M; Otsuji E; Honda A; Itoh Y
    Biomarkers; 2021 Jul; 26(5):462-467. PubMed ID: 33926316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteomics for early detection of colorectal cancer: recent updates.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.